ProKidney Corp.

IPO

ProKidney Corp. is a biotech company in United States, founded in 2015. It has raised $130.0M across 1 round, most recently a $130.0M Venture Round in June 2024.

ProKidney - Pioneers in the Treatment of Chronic Kidney Disease

Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$130.0M
Last Round
$130.0M Venture RoundJun 2024
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

ProKidney is a late-clinical-stage biotechnology company developing rilparencel, a first-of-its-kind autologous cell therapy designed to preserve kidney function and delay dialysis for people with advanced chronic kidney disease. As the only company developing an autologous cell therapy specifically for advanced CKD, it is evaluating rilparencel in the Phase 3 REGEN-006 (PROACT 1) trial for patients with Stage 3b and 4 CKD and type 2 diabetes across more than 70 clinical sites in the United States, Asia, and Latin America. The company is initially pursuing REACT for moderate to severe CKD patients with diabetes as the primary cause.

Summary

It lists 51–200 employees. It has raised $130.0M in total across 1 round, most recently a $130.0M Venture Round in Jun 2024. Investors include Social Capital Suvretta Holdings Corp. III.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Venture RoundVenture RoundJun 2024
$130.0M

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ProKidney Corp. on Indexed.vc
<a href="https://indexed.vc/companies/prokidney-corp"><img src="https://indexed.vc/api/badge/company/prokidney-corp" alt="ProKidney Corp. on Indexed.vc" width="260" height="76" /></a>